Sijie Li

729 total citations
25 papers, 478 citations indexed

About

Sijie Li is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Sijie Li has authored 25 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 12 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Sijie Li's work include Circular RNAs in diseases (9 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (7 papers). Sijie Li is often cited by papers focused on Circular RNAs in diseases (9 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (7 papers). Sijie Li collaborates with scholars based in China, United States and Ethiopia. Sijie Li's co-authors include Hongyao Jia, Zhiru Zhang, Di Wu, Dehai Yu, Di Wu, Zhuo Li, Haijun Li, You Lv, Zhaoyi Wang and Bing Han and has published in prestigious journals such as Scientific Reports, Advanced Science and Cancer Letters.

In The Last Decade

Sijie Li

22 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sijie Li China 14 321 257 87 50 31 25 478
Juan Zou China 13 241 0.8× 147 0.6× 70 0.8× 75 1.5× 30 1.0× 36 416
Liza J. Burton United States 11 296 0.9× 161 0.6× 138 1.6× 57 1.1× 21 0.7× 13 472
Adnan Merdad Saudi Arabia 11 268 0.8× 178 0.7× 120 1.4× 43 0.9× 43 1.4× 27 489
Yeting Hong China 13 499 1.6× 400 1.6× 51 0.6× 29 0.6× 38 1.2× 23 631
R. Benjamin Isett United States 9 306 1.0× 164 0.6× 62 0.7× 48 1.0× 51 1.6× 12 452
Mei Yieng Chin Canada 14 367 1.1× 152 0.6× 64 0.7× 74 1.5× 27 0.9× 19 516
Yanting Zhou China 11 257 0.8× 101 0.4× 83 1.0× 31 0.6× 24 0.8× 37 419
Prajakta Oak Germany 9 298 0.9× 118 0.5× 115 1.3× 107 2.1× 28 0.9× 16 468

Countries citing papers authored by Sijie Li

Since Specialization
Citations

This map shows the geographic impact of Sijie Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sijie Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sijie Li more than expected).

Fields of papers citing papers by Sijie Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sijie Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sijie Li. The network helps show where Sijie Li may publish in the future.

Co-authorship network of co-authors of Sijie Li

This figure shows the co-authorship network connecting the top 25 collaborators of Sijie Li. A scholar is included among the top collaborators of Sijie Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sijie Li. Sijie Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Sijie, et al.. (2026). Bacterial Outer Membrane Vesicles in Potentiating Cancer Vaccines: Progress and Prospects. Advanced Science. e21684–e21684.
3.
Zhang, Xiaoxiao, et al.. (2022). Research progress on immunotherapy in triple‑negative breast cancer (Review). International Journal of Oncology. 61(2). 18 indexed citations
4.
Liu, Chang, Sijie Li, Xiaoxiao Zhang, et al.. (2022). Nogo-B receptor increases glycolysis and the paclitaxel resistance of estrogen receptor-positive breast cancer via the HIF-1α-dependent pathway. Cancer Gene Therapy. 30(5). 647–658. 12 indexed citations
5.
Yin, Siyang, Ziti Jiao, Yadong Dong, et al.. (2022). Evaluation of the Consistency of the Vegetation Clumping Index Retrieved from Updated MODIS BRDF Data. Remote Sensing. 14(16). 3997–3997. 4 indexed citations
7.
Yu, Dehai, et al.. (2021). Relationship between p53 status and the bioeffect of ionizing radiation (Review). Oncology Letters. 22(3). 661–661. 35 indexed citations
8.
Liu, Weifang, Wei Chen, Xiu‐Xiang Zhang, et al.. (2021). Higher efficacy and reduced adverse reactions in neoadjuvant chemotherapy for breast cancer by using pegylated liposomal doxorubicin compared with pirarubicin. Scientific Reports. 11(1). 199–199. 13 indexed citations
9.
Wu, Di, Hongyao Jia, Zhiru Zhang, & Sijie Li. (2021). STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD. Bioorganic Chemistry. 109. 104722–104722. 11 indexed citations
10.
Wang, Jing, Wanru Liu, Dehai Yu, et al.. (2021). Research Progress on the Treatment of Premature Ovarian Failure Using Mesenchymal Stem Cells: A Literature Review. Frontiers in Cell and Developmental Biology. 9. 749822–749822. 20 indexed citations
11.
Li, Sijie, Hongyao Jia, Zhiru Zhang, & Di Wu. (2021). DRAIC promotes growth of breast cancer by sponging miR-432-5p to upregulate SLBP. Cancer Gene Therapy. 29(7). 951–960. 18 indexed citations
12.
Xiao, Feng, et al.. (2021). LINC01234 aggravates cell growth and migration of triple‐negative breast cancer by activating the Wnt pathway. Environmental Toxicology. 36(10). 1999–2012. 16 indexed citations
13.
Jia, Hongyao, Di Wu, Zhiru Zhang, & Sijie Li. (2020). TCF3-activated FAM201A enhances cell proliferation and invasion via miR-186-5p/TNKS1BP1 axis in triple-negative breast cancer. Bioorganic Chemistry. 104. 104301–104301. 17 indexed citations
14.
Jia, Hongyao, Di Wu, Zhiru Zhang, & Sijie Li. (2020). Regulatory effect of the MAFG‑AS1/miR‑150‑5p/MYB axis on the proliferation and migration of breast cancer cells. International Journal of Oncology. 58(1). 33–44. 28 indexed citations
15.
Li, Sijie, Di Wu, Hongyao Jia, & Zhiru Zhang. (2020). Long non-coding RNA LRRC75A-AS1 facilitates triple negative breast cancer cell proliferation and invasion via functioning as a ceRNA to modulate BAALC. Cell Death and Disease. 11(8). 643–643. 30 indexed citations
16.
Zhang, Hong, Tao Zhu, Ruoqiu Fu, et al.. (2020). Combination of Detoxified Pneumolysin Derivative ΔA146Ply and Berbamine as a Treatment Approach for Breast Cancer. Molecular Therapy — Oncolytics. 18. 247–261. 11 indexed citations
17.
Wu, Di, Hongyao Jia, Zhiru Zhang, & Sijie Li. (2020). Circ‐PRMT5 promotes breast cancer by the miR‐509‐3p/TCF7L2 axis activating the PI3K/AKT pathway. The Journal of Gene Medicine. 23(2). e3300–e3300. 30 indexed citations
18.
Jin, Ying, Wenquan Hu, Tong Liu, et al.. (2018). Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel. Cancer Letters. 419. 233–244. 15 indexed citations
19.
Gao, Pin, Xiang Wang, Ying Jin, et al.. (2018). Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells. Breast Cancer Research. 20(1). 112–112. 11 indexed citations
20.
Du, Ye, Aiping Shi, Bing Han, et al.. (2014). COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro. International Journal of Oncology. 44(4). 1385–1393. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026